Periprocedural bleeding, acute kidney injury, and long-term mortality after transcatheter aortic valve implantation

Canadian Journal of Cardiology

Volumn 31, Issue 1, 2015, Pages 56-62

  Konigstein, Maayan ^a   Ben Assa, Eyal ^a   Banai, Shmuel ^a   Shacham, Yacov ^a   Ziv Baran, Tomer ^a   Abramowitz, Yigal ^a   Steinvil, Arie ^a   Leshem Rubinow, Eran ^a   Havakuk, Ofer ^a   Halkin, Amir ^a   Keren, Gad ^a   Finkelstein, Ariel ^a   Arbel, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA STENOSIS; ARTICLE; CLINICAL TRIAL; DISEASE CLASSIFICATION; FATAL BLEEDING; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIFE THREATENING BLEEDING; MAJOR BLEEDING; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS AORTIC VALVE; PERIPROCEDURAL BLEEDING; PEROPERATIVE COMPLICATION; PROSPECTIVE STUDY; SURVIVAL PREDICTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VALVE ACADEMIC RESEARCH CONSORTIUM 2 ACUTE KIDNEY FAILURE CLASSIFICATION; ACUTE KIDNEY INJURY; AORTIC VALVE STENOSIS; COMPLICATION; INCIDENCE; ISRAEL; MORTALITY; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TIME; TRENDS; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISRAEL; MALE; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84920468338     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.11.006     Document Type: Article

References (36)

1. Elhmidi Y., Bleiziffer S., Piazza N., et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011, 161:735-739.
2. Khawaja M.Z., Thomas M., Joshi A., et al. The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 2012, 8:563-570.
3. Nuis R.J., Van Mieghem N.M., Tzikas A., et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011, 77:881-889.
4. Podolecka E., Chmielak Z., Demkow M., et al. Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function?. Kardiol Pol 2011, 69:251-255.
5. Saia F., Ciuca C., Taglieri N., et al. Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Int J Cardiol 2013, 168:1034-1040.
6. Leon M.B., Piazza N., Nikolsky E., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217.
7. Genereux P., Kodali S.K., Green P., et al. Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol 2013, 111:100-105.
8. Kong W.Y., Yong G., Irish A. Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology (Carlton) 2012, 17:445-451.
9. Aregger F., Wenaweser P., Hellige G.J., et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009, 24:2175-2179.
10. Konigstein M., Ben-Assa E., Abramowitz Y., et al. Usefulness of updated valve academic research consortium-2 criteria for acute kidney injury following transcatheter aortic valve implantation. Am J Cardiol 2013, 112:1807-1811.
11. Nuis R.J., Rodes-Cabau J., Sinning J.M., et al. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012, 5:680-688.
12. Sinning J.M., Ghanem A., Steinhauser H., et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010, 3:1141-1149.
13. Barbash I.M., Ben-Dor I., Dvir D., et al. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 2012, 163:1031-1036.
14. Bagur R., Webb J.G., Nietlispach F., et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010, 31:865-874.
15. Borz B., Durand E., Godin M., et al. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 2013, 99:860-885.
16. Pilgrim T., Kalesan B., Wenaweser P., et al. Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis. Circ Cardiovasc Interv 2012, 5:856-861.
17. Halliday B.P., Dworakowski R., Brickham B., et al. Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation. Am J Cardiol 2012, 109:724-728.
18. Gurvitch R., Toggweiler S., Willson A.B., et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011, 7:41-48.
19. Genereux P., Cohen D.J., Williams M.R., et al. Bleeding Complications after Surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). JAm Coll Cardiol 2014, 63:1100-1109.
20. Genereux P., Head S.J., Van Mieghem N.M., et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. JAm Coll Cardiol 2012, 59:2317-2326.
21. Genereux P., Webb J.G., Svensson L.G., et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. JAm Coll Cardiol 2012, 60:1043-1052.
22. Pilgrim T., Stortecky S., Luterbacher F., et al. Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis. JThromb Thrombolysis 2013, 35:456-462.
23. Nishimura R.A., Otto C.M., Bonow R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129:e521-e643.
24. Boothroyd L.J., Spaziano M., Guertin J.R., et al. Transcatheter aortic valve implantation: recommendations for practice based on a multidisciplinary review including cost-effectiveness and ethical and organizational issues. Can J Cardiol 2013, 29:718-726.
25. Webb J., Rodes-Cabau J., Fremes S., et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol 2012, 28:520-528.
26. Seeliger E., Sendeski M., Rihal C.S., et al. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J 2012, 33:2007-2015.
27. Kappetein A.P., Head S.J., Genereux P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. JThorac Cardiovasc Surg 2013, 145:6-23.
28. Arbel Y., Ben-Assa E., Halkin A., et al. Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial. Trials 2014, 15:262.
29. Ohno Y., Maekawa Y., Miyata H., et al. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. JAm Coll Cardiol 2013, 62:1260-1266.
30. Kahlert P., Al-Rashid F., Plicht B., et al. Suture-mediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc Interv 2013, 81:E139-E150.
31. Abi Rafeh N., Quevedo H.C., DeAndrade K.B., et al. The double angio-seal technique for arterial closure following large-bore access. JInvasive Cardiol 2013, 25:412-414.
32. Ben-Dor I., Looser P., Bernardo N., et al. Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual. Catheter Cardiovasc Interv 2011, 78:119-124.
33. Buchanan G.L., Chieffo A., Montorfano M., et al. A"modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013, 81:579-583.
34. Borz B., Durand E., Tron C., et al. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications. Catheter Cardiovasc Interv 2014, 83:E227-E232.
35. Sedaghat A., Sinning J.M., Werner N. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2013, 82:E613-E616.
36. Barbanti M., Binder R.K., Freeman M., et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention 2013, 9:929-935.